Quality of life of patients with coronary heart disease treated with the bioresorbable vascular scaffold (absorb™): 2-year results from the gabi-r-registry

HIGHLIGHTS

• who: Kathrin Pahmeier from the Institute for Health Care Management and Research, University DuisburgEssen, Thea‑Leymann‑Str9, Essen, Germany have published the research: Quality of life of patients with coronary heart disease treated with the bioresorbable vascular scaffold (ABSORB™): 2-year results from the GABI-R-registry, in the Journal: (JOURNAL)
• what: In this analysis of the German-Austrian ABSORB RegIstRy the 2 year results concerning quality of life development in a large cohort of patients treated with BVS were reported.

SUMMARY

Patients with coronary heart disease (CHD) have substantial physical . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.